Clinical Characteristics of Coronavirus Disease 2019 in China
2020 · New England Journal of Medicine · 31K citations
https://doi.org/10.1056/nejmoa2002032
W
Wenhua Liang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
536
Papers
60.1K
Citations
61
h-index
239
i10-index
Wenhua Liang is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Lung Cancer Research Studies. The author has an h-index of 61, co-authored 456 publications.
ORCID: 0000-0002-1391-8238Papers by this author
worksComorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
2020 · European Respiratory Journal · 3,734 citations
https://doi.org/10.1183/13993003.00547-2020
Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography
2020 · Cell · 938 citations
https://doi.org/10.1016/j.cell.2020.04.045
EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
2014 · Oncotarget · 382 citations
https://doi.org/10.18632/oncotarget.2608
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
2021 · EClinicalMedicine · 343 citations
https://doi.org/10.1016/j.eclinm.2021.101134
Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas
2015 · Nature Communications · 112 citations
https://doi.org/10.1038/ncomms10131
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat